Login / Signup

An update on pharmacotherapy for trigeminal neuralgia.

Joseph V PergolizziJo Ann LeQuangSalah N El-TallawyMorgan WagnerRania S AhmedGuistino Varassi
Published in: Expert review of neurotherapeutics (2024)
In real-world clinical practice, about half of trigeminal neuralgia patients take more than one agent for prevention and combination therapy may be the optimal approach. Combination therapy might allow for lower doses of carbamazepine or oxcarbazepine, thus reducing the number and severity of potential adverse events but the potential for pharmacokinetic drug-drug interactions must be considered. Drug therapy for trigeminal neuralgia involves acute or abortive treatments, often administered in hospital versus long-term preventive therapy, usually involving oral agents.
Keyphrases